Skip to main content
Equibles

MetLife Investment Management, LLC

Position in IMVT — Immunovant, Inc.

CIK 1529735 Whippany, NJ
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,914,054
+$809,643 QoQ
Shares Held
49,677
+11.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#90
of 226 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. IMVT ranks #47 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in IMVT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,914,054 49,677
2026-03-31 $1,104,411 44,461
2025-12-31 $992,295 39,036
2025-09-30 $659,308 40,900
2025-06-30 $654,400 40,900
2025-03-31 $599,773 35,095
2024-12-31 $883,000 35,648
2024-09-30 $958,164 33,608
2024-06-30 $887,251 33,608
2024-03-31 $920,091 28,477
2023-12-31 $1,199,736 28,477
2023-09-30 $1,093,232 28,477
2023-06-30 $540,208 28,477
2023-03-31 $347,268 22,390
2022-12-31 $384,234 21,647
2022-09-30 $120,790 21,647
2022-03-31 $138,763 25,184
2021-12-31 $40,955 4,807
2021-09-30 $130,428 15,009
2021-06-30 $44,489 4,209
2021-03-31 $240,712 15,007
2020-12-31 $693,173 15,007
2020-09-30 $528,096 15,007
2020-06-30 $230,034 9,447